...
nspr-img

InspireMD Inc, Common Stock

NSPR

NAQ

$2.95

-$0.05

(-1.67%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$78.25M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
9.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.93
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.81 L
$3.42 H
$2.95

About InspireMD Inc, Common Stock

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameNSPRSectorS&P500
1-Week Return1.72%-0.94%-2.6%
1-Month Return0.34%-5.08%-1.08%
3-Month Return6.88%-10.62%3.45%
6-Month Return16.14%-6.18%8.57%
1-Year Return27.71%1.98%24.3%
3-Year Return-9.79%-0.93%25.58%
5-Year Return-79.51%33.84%84.07%
10-Year Return-100%102.52%185.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.72M2.48M4.50M5.17M6.21M[{"date":"2019-12-31","value":59.97,"profit":true},{"date":"2020-12-31","value":40.05,"profit":true},{"date":"2021-12-31","value":72.44,"profit":true},{"date":"2022-12-31","value":83.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue2.96M2.40M3.74M4.05M4.40M[{"date":"2019-12-31","value":67.42,"profit":true},{"date":"2020-12-31","value":54.62,"profit":true},{"date":"2021-12-31","value":85.06,"profit":true},{"date":"2022-12-31","value":92.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit756.00K83.00K754.00K1.12M1.81M[{"date":"2019-12-31","value":41.84,"profit":true},{"date":"2020-12-31","value":4.59,"profit":true},{"date":"2021-12-31","value":41.73,"profit":true},{"date":"2022-12-31","value":61.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin20.32%3.34%16.77%21.60%29.12%[{"date":"2019-12-31","value":69.77,"profit":true},{"date":"2020-12-31","value":11.47,"profit":true},{"date":"2021-12-31","value":57.6,"profit":true},{"date":"2022-12-31","value":74.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses10.57M10.46M15.47M19.83M22.95M[{"date":"2019-12-31","value":46.07,"profit":true},{"date":"2020-12-31","value":45.59,"profit":true},{"date":"2021-12-31","value":67.41,"profit":true},{"date":"2022-12-31","value":86.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(9.82M)(10.38M)(14.72M)(18.71M)(21.14M)[{"date":"2019-12-31","value":-981600000,"profit":false},{"date":"2020-12-31","value":-1038000000,"profit":false},{"date":"2021-12-31","value":-1471600000,"profit":false},{"date":"2022-12-31","value":-1871300000,"profit":false},{"date":"2023-12-31","value":-2114300000,"profit":false}]
Total Non-Operating Income/Expense(400.00K)(320.00K)(314.00K)500.00K2.58M[{"date":"2019-12-31","value":-15.48,"profit":false},{"date":"2020-12-31","value":-12.38,"profit":false},{"date":"2021-12-31","value":-12.15,"profit":false},{"date":"2022-12-31","value":19.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(10.02M)(10.54M)(14.87M)(18.46M)(19.85M)[{"date":"2019-12-31","value":-1001600000,"profit":false},{"date":"2020-12-31","value":-1054000000,"profit":false},{"date":"2021-12-31","value":-1487300000,"profit":false},{"date":"2022-12-31","value":-1846300000,"profit":false},{"date":"2023-12-31","value":-1985100000,"profit":false}]
Income Taxes24.00K4.00K45.00K28.00K65.00K[{"date":"2019-12-31","value":36.92,"profit":true},{"date":"2020-12-31","value":6.15,"profit":true},{"date":"2021-12-31","value":69.23,"profit":true},{"date":"2022-12-31","value":43.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(10.04M)(10.54M)(14.92M)(18.49M)(19.92M)[{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}]
Income From Continuous Operations(10.04M)(10.54M)(14.92M)(18.49M)(19.92M)[{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(10.04M)(10.54M)(14.92M)(18.49M)(19.92M)[{"date":"2019-12-31","value":-1004000000,"profit":false},{"date":"2020-12-31","value":-1054400000,"profit":false},{"date":"2021-12-31","value":-1491800000,"profit":false},{"date":"2022-12-31","value":-1849100000,"profit":false},{"date":"2023-12-31","value":-1991600000,"profit":false}]
EPS (Diluted)(108.60)(11.55)(2.05)(2.34)(1.08)[{"date":"2019-12-31","value":-10860,"profit":false},{"date":"2020-12-31","value":-1155,"profit":false},{"date":"2021-12-31","value":-205,"profit":false},{"date":"2022-12-31","value":-234,"profit":false},{"date":"2023-12-31","value":-108,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NSPR
Cash Ratio 5.56
Current Ratio 6.39
Quick Ratio 6.05

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NSPR
ROA (LTM) -37.24%
ROE (LTM) -66.75%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NSPR
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NSPR
Trailing PE NM
Forward PE 11.70
P/S (TTM) 11.28
P/B 1.86
Price/FCF NM
EV/R 5.54
EV/Ebitda 0.52
PEG NM

FAQs

What is InspireMD Inc share price today?

InspireMD Inc (NSPR) share price today is $2.95

Can Indians buy InspireMD Inc shares?

Yes, Indians can buy shares of InspireMD Inc (NSPR) on Vested. To buy InspireMD Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NSPR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of InspireMD Inc be purchased?

Yes, you can purchase fractional shares of InspireMD Inc (NSPR) via the Vested app. You can start investing in InspireMD Inc (NSPR) with a minimum investment of $1.

How to invest in InspireMD Inc shares from India?

You can invest in shares of InspireMD Inc (NSPR) via Vested in three simple steps:

  • Click on Sign Up or Invest in NSPR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in InspireMD Inc shares
What is InspireMD Inc 52-week high and low stock price?

The 52-week high price of InspireMD Inc (NSPR) is $3.42. The 52-week low price of InspireMD Inc (NSPR) is $1.81.

What is InspireMD Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of InspireMD Inc (NSPR) is

What is InspireMD Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of InspireMD Inc (NSPR) is 1.86

What is InspireMD Inc dividend yield?

The dividend yield of InspireMD Inc (NSPR) is 0.00%

What is the Market Cap of InspireMD Inc?

The market capitalization of InspireMD Inc (NSPR) is $78.25M

What is InspireMD Inc’s stock symbol?

The stock symbol (or ticker) of InspireMD Inc is NSPR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top